![](/img/cover-not-exists.png)
Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: results of a phase II trial
Adam D. Cohen, Ping Zhou, Joanne Chou, Julie Teruya-Feldstein, Lilian Reich, Hani Hassoun, Beth Levine, Daniel A. Filippa, Elyn Riedel, Tarun Kewalramani, Michael D. Stubblefield, Martin Fleisher, SteVolume:
139
Year:
2007
Language:
english
Pages:
10
DOI:
10.1111/j.1365-2141.2007.06783.x
File:
PDF, 203 KB
english, 2007